Evidence map›Paper›PMID 41763199›Full record

ArticleCell2026

Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle.

Abigail Xie, Julia S Brunner, Sangita Chakraborty, Angela M Montero, Anna E Bridgeman, Katrina I Paras, Ruobing Cui, Maider Fagoaga-Eugui, Monika Komza, Paige K Arnold and 5 more

Abstract read
In one paragraph

Article in Cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Abigail XieCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY 10065, USA.
Julia S BrunnerCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sangita ChakrabortyCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Angela M MonteroCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Anna E BridgemanCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Katrina I ParasCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Ruobing CuiCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Maider Fagoaga-EuguiCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Monika KomzaCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY 10065, USA.
Paige K ArnoldCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Benjamin T JacksonCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, New York, NY 10065, USA.
Santiago Noriega MadrazoCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY 10065, USA.
Mohamed I AtmaneLaboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University, New York, NY 10065, USA.
Sebastian E CarrascoLaboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University, New York, NY 10065, USA.
Lydia W S FinleyCell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: finleyl@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Michael Jason de la Cruz · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan Kettering MST ProgramT32GM152349 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KATHARINE C HSU · 2024 to 2026
$6.6M
Training Program in Developmental BiologyT32HD060600 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BAO, ZHIRONG, STUHLMANN, HEIDI · 2010 to 2024
$3.5M
Metabolic vulnerabilities in cancers with impaired TCA cycle activityF30CA284711 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Abigail Xie · 2023 to 2026
$216k
Metabolic control of exit from naïve pluripotencyF30HD107943 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI JACKSON, BENJAMIN TONNU · 2022 to 2025
$184k
Identifying the metabolic requirements for the TCA cycle in embryonic developmentF31HD119933 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI Angela Margaret Montero · 2025 to 2026
$100k
NCI NIH HHS F30 CA284711NCI NIH HHS P30 CA008748NICHD NIH HHS F30 HD107943NICHD NIH HHS F31 HD119933NICHD NIH HHS T32 HD060600NIGMS NIH HHS T32 GM152349
6 · The paper itself

Abstract

The tricarboxylic acid (TCA) cycle couples nutrient oxidation with the generation of reducing equivalents that power oxidative phosphorylation. Nevertheless, the requirement for components of the TCA cycle is context-specific, raising the question of which TCA cycle outputs support cell fitness. Here, we demonstrate that citrate clearance is an essential function of the TCA cycle. As citrate production increases, so do TCA cycle activity and dependence upon aconitase 2 (ACO2), the enzyme that initiates citrate catabolism in the TCA cycle. Disrupting citrate catabolism activates the integrated stress response and impairs cell fitness, and these effects are reversed by preventing citrate production or promoting mitochondrial citrate efflux. In vivo, ACO2 deficiency induces citrate accumulation and triggers tubular degeneration in the kidney, a tissue that physiologically takes up circulating citrate. Thus, intracellular citrate accumulation can be a metabolic liability, and citrate clearance is a major function of ACO2 in the TCA cycle.

Indexed as

Aconitate HydrataseCitric AcidCitric Acid CycleAnimalsHumansIntegrated Stress ResponseKidneyMiceMitochondriaACO2 protein, humanAconitate HydrataseCitric AcidACO2cell metabolismcitrateintegrated stress responseTCA cycle

Identifiers

PMID41763199
PMCPMC13045649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.